Company

Kano Therapeutics

Biotechnology Research Cambridge, Massachusetts, United States 13 employees IPO

Employees: 13
Contacts: 3
Emails: 3
Phones: 1

www.kanotherapeutics.com LinkedIn Crunchbase

Kano Therapeutics Overview

Headquarters: Cambridge, Massachusetts, United States
Website: www.kanotherapeutics.com
Industry: Biotechnology Research
Employees: 13
Founded: 2021
Stock Symbol: IPO
Funding: 5.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotechnology DNA therapeutics Gene therapy CRISPR Biological engineering

About Kano Therapeutics

Kano Therapeutics is a biotech startup enabling safe, effective, and flexible correction of gene-length stretches of DNA through a new class of biomaterials: circular single-stranded DNA. By building a “one stop shop” product development platform for single-stranded DNA templates that combines manufacturing, application, and computational tools we bridge the gap between editing genes and totally replacing them.

Kano Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Kano Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
John Vroom	Co-founder @ Kano Therapeutics	Greater Boston, United States	Email
Mark Bathe	Professor of Biological Engineering	Cambridge, Massachusetts, United States	Email Phone
Scott Hamilton	Director of Cmc - Biopharmaceutical		View
Nicholas Gentile	Process Development	Greater Boston, United States	Email